Cargando…

Glucagon: its significance in health and disease.

Detalles Bibliográficos
Autor principal:	Trimble, E. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Ulster Medical Society 1976
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2385557/ https://www.ncbi.nlm.nih.gov/pubmed/936359

Ejemplares similares

Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance
por: Jung, Min Jung, et al.
Publicado: (2014)

Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes
por: Yang, Jianxin, et al.
Publicado: (2011)

Glucagon and Its Receptors in the Mammalian Heart
por: Neumann, Joachim, et al.
Publicado: (2023)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes
por: Jia, Yunbo, et al.
Publicado: (2022)

Glucagon : its role in physiology and clinical medicine
Publicado: (1977)

Significance of Blood Sugar and Serum Electrolyte Changes in Cirrhosis Following Glucose, Insulin, Glucagon, or Epinephrine
por: Danowski, T. S., et al.
Publicado: (1956)

Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes
por: Watts, Gerald F., et al.
Publicado: (2013)

Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation
por: Funakoshi-Tago, Megumi, et al.
Publicado: (2020)

Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish
por: Kang, Qi, et al.
Publicado: (2022)

Generation of glucagon‐like peptide‐2‐expressing Saccharomyces cerevisiae and its improvement of the intestinal health of weaned rats
por: Zhang, Zhongwei, et al.
Publicado: (2016)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009)

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2016)

Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart
por: Aranda-Domene, Ramón, et al.
Publicado: (2023)

Newly discovered knowledge pertaining to glucagon and its clinical applications
por: Kawamori, Dan, et al.
Publicado: (2023)

Glucagon changes substrate preference in gluconeogenesis
por: Xu, Huiting, et al.
Publicado: (2022)

Misrouting of glucagon and stathmin-2 towards lysosomal system of α-cells in glucagon hypersecretion of diabetes
por: Asadi, Farzad, et al.
Publicado: (2021)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

The Profession of Medicine and its Rivals
por: Trimble, Michael
Publicado: (2016)

Problem or solution: The strange story of glucagon
por: Scott, R.V., et al.
Publicado: (2018)

Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2014)

Intraperitoneal and subcutaneous glucagon delivery in anaesthetized pigs: effects on circulating glucagon and glucose levels
por: Åm, Marte Kierulf, et al.
Publicado: (2020)

Abscisic Acid Stimulates Glucagon-Like Peptide-1 Secretion from L-Cells and Its Oral Administration Increases Plasma Glucagon-Like Peptide-1 Levels in Rats
por: Bruzzone, Santina, et al.
Publicado: (2015)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue “The Biology and Pharmacology of Glucagon”
por: Müller, Timo D., et al.
Publicado: (2020)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis
por: Xie, Fei-Fei, et al.
Publicado: (2022)

Basal Metabolism of Indians in Health and Disease—Its Clinical Significance
por: Bose, J. P., et al.
Publicado: (1934)

Modulation of β-Catenin Signaling by Glucagon Receptor Activation
por: Ke, Jiyuan, et al.
Publicado: (2012)

Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
por: Tan, Tricia M., et al.
Publicado: (2013)

Copeptin under glucagon stimulation
por: Lewandowski, Krzysztof C., et al.
Publicado: (2015)

Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer
por: Kanda, Ranka, et al.
Publicado: (2018)

Molecular Characterization of Grass Carp GIPR and Effect of Nutrition States, Insulin, and Glucagon on Its Expression
por: Yang, Guokun, et al.
Publicado: (2022)

Salivary Hormones Leptin, Ghrelin, Glucagon, and Glucagon-Like Peptide 1 and Their Relation to Sweet Taste Perception in Diabetic Patients
por: Al-Ghurayr, Nada K., et al.
Publicado: (2023)

(13)C(15)N: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans
por: Renuse, Santosh, et al.
Publicado: (2022)

The ubiquitination status of the glucagon receptor determines signal bias
por: Kaur, Suneet, et al.
Publicado: (2023)

Basal Metabolism of Indians in Health and Disease: Its Clinical Significance
por: Gupta, P. C.
Publicado: (1935)

Glucagon secretion and signaling in the development of diabetes
por: Gaisano, Herbert Y., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1s0frsb6f6a6mjeg0l5ru4k70p